Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism

Clinical and Laboratory Haematology

Volumn 28, Issue 2, 2006, Pages 111-116

  Jun, Z J ^a   Ping, T ^a   Lei, Y ^a   Li, L ^a   Ming, S Y ^a   Jing, W ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Deep venous thrombosis; Factor V Leiden; Mutation; Prothrombin G20210A; Pulmonary embolism; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA; PROTHROMBIN;

ADULT; AGE; ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; ECHOGRAPHY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HUMAN; HUMAN TISSUE; IMMOBILIZATION; INJURY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PHLEBOGRAPHY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STATISTICAL ANALYSIS; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTHROMBIN; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 33645296094     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00757.x     Document Type: Article

References (34)

1. Alhenc-Gelas M. Arnaud E. Nicaud V. Aubry M.L. Fiessinger J.N. Aiach M. Emmerich J. 1999 Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thrombosis and Haemostasis 81 506 510.
2. Angchaisuksiri P. Pingsuthiwong S. Aryuchai K. Busabaratana M. Sura T. Atichartakarn V. Sritara P. 2000 Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. American Journal of Hematology 65 119 122.
3. Arruda V.R. Annichino-Bizzacchi J.M. Goncalves M.S. Costa F.F. 1997 Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thrombosis and Haemostasis 78 1430 1433.
4. Bertina R.M. Koeleman B.P. Koster T. Rosendaal F.R. Dirven R.J. de Ronde H. van der Velden P.A. Reitsma P.H. 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 64 67.
5. Brown K. Luddington R. Williamson D. Baker P. Baglin T. 1997 Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology 98 907 909.
6. Cattaneo M. Chantarangkul V. Taioli E. Santos J.H. Tagliabue L. 1999 The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thrombosis Research 93 1 8.
7. Chan C.W. Hoaglund F.T. 1980 Pulmonary thromboembolism and venous thrombosis in the Chinese. Clinical Orthopaedics and Related Research 150 253 260.
8. Cumming A.M. Keeney S. Salden A. Bhavnani M. Shwe K.H. Hay C.R. 1997 The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. British Journal of Haematology 98 353 355.
9. Dahlback B. Carlsson M. Svensson P.J. 1993 Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90 1004 1008.
10. De Stefano V. Chiusolo P. Paciaroni K. Casorelli I. Di Mario A. Rossi E. Leone G. 1998 Prevalence of the factor II G20210A mutation in symptomatic patients with inherited thrombophilia. Thrombosis and Haemostasis 80 342 343.
11. Eichinger S. Pabinger I. Stumpflen A. Hirschl M. Bialonczyk C. Schneider B. Mannhalter C. Minar E. Lechner K. Kyrle P.A. 1997 The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thrombosis and Haemostasis 77 624 628.
12. Fujimura H. Kambayash J. Monden M. Kato H. Miyata T. 1995 Coagulation factor V Leiden mutation may have a racial background. Thrombosis and Haemostasis 74 1381 1383.
13. Hillarp A. Zoller B. Svensson P.J. Dahlback B. 1997 The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thrombosis and Haemostasis 78 990 992.
14. Kim T.W. Kim W.K. Lee J.H. Kim S.B. Kim S.W. Suh C. Lee K.H. Lee J.S. Seo E.J. Chi H.S. Kim S.H. 1998 Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. Journal of Korean Medical Science 13 587 590.
15. Kniffin W.D. Jr. Baron J.A. Barrett J. Birkmeyer J.D. Anderson F.A. Jr. 1994 The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Archives of Internal Medicine 154 861 866.
16. Manten B. Westendorp R.G. Koster T. Reitsma P.H. Rosendaal F.R. 1996 Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thrombosis and Haemostasis 76 510 513.
17. Margaglione M. Brancaccio V. Giuliani N. D'Andrea G. Cappucci G. Iannaccone L. Vecchione G. Grandone E. Di Minno G. 1998 Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant. Annals of Internal Medicine 129 89 93.
18. Margaglione M. Brancaccio V. De Lucia D. Martinelli I. Ciampa A. Grandone E. Di Minno G. 2000 Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 118 1405 1411.
19. Martinelli I. Cattaneo M. Panzeri D. Mannucci P.M. 1997 Low prevalence of factor V: Q506 in 41 patients with isolated pulmonary embolism. Thrombosis and Haemostasis 77 440 443.
20. Oger E. 2000 Incidence of venous thromboembolism: a community-based study in Western France. Thrombosis and Haemostasis 83 657 660.
21. Poncz M. Solowiejczyk D. Harpel B. Mory Y. Schwartz E. Surry S. 1982 Construction of human gene libraries from small amounts of peripheral blood: analysis of β-like globin genes. Hemoglobin 6 27 36.
22. Poort S.R. Rosendaal F.R. Reitsma P.H. Bertina R.M. 1996 A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 3698 3703.
23. Rees D.C. Cox M. Clegg J.B. 1995 World distribution of factor V Leiden. Lancet 346 1133 1134.
24. Ridker P.M. Hennekens C.H. Lindpaintner K. Stampfer M.J. Eisenberg P.R. Miletich J.P. 1995 Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New England Journal of Medicine 332 912 917.
25. Rosendaal F.R. Koster T. Vandenbroucke J.P. Reitsma P.H. 1995 High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 1504 1508.
26. Rosendaal F.R. Doggen C.J. Zivelin A. Arruda V.R. Aiach M. Siscovick D.S. Hillarp A. Watzke H.H. Bernardi F. Cumming A.M. Preston F.E. Reitsma P.H. 1998 Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis 79 706 708.
27. Salzman E.W. Hirsh J. 1994 The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Hemostasis and Thrombosis Basic Principle and Practice eds Colman R.W. Hirsh J. Marder V.J. Salzman E.W. pp. 1275 1296. J B Lippincott Salzman E.W. Marder V.J. Hirsh J. Colman R.W.
28. Seligsohn U. Lubetsky A. 2001 Genetic susceptibility to venous thrombosis. New England Journal of Medicine 344 1222 1231.
29. Torbicki A. van Beek E.J.R. Charbonnier B. Charbonnier B. Meyer G. Morpurgo M. Palla A. Perrier A. 2000 Guidelines on diagnosis and management of acute pulmonary embolism. European Heart Journal 21 1301 1336.
30. Voorberg J. Roelse J. Koopman R. Buller H. Berends F. ten Cate J.W. Mertens K. van Mourik J.A. 1994 Association of idiopathic thromboembolism with single point-mutation at Arg506 of factor V. Lancet 343 1535 1536.
31. Watanabe H. Hamada H. Yamada N. Sohda S. Yamakawa-Kobayashi K. Yoshikawa H. Arinami T. 2002 Association analysis of nine missense polymorphisms in the coagulation factor V gene with severe preeclampsia in pregnant Japanese women. J Hum Genet 47 131 135.
32. White R.H. Zhou H. Romano P.S. 1998 Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Annals of Internal Medicine 128 737 740.
33. Zoller B. Dahlback B. 1994 Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343 1536 1538.
34. Zoller B. Svensson P.J. He X. Dahlback B. 1994 Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation 94 2521 2524.